NCT03064945View on ClinicalTrials.gov

The Effectiveness and Safety of LIVIA® Transcutaneous Electrical Nerve Stimulation (TENS) in Women Suffering From Primary Dysmenorrhea.

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

April 25, 2018

Study Completion Date

April 25, 2018

Conditions

Dysmenorrhea

Interventions

DEVICE

Livia

Livia® Transcutaneous Electrical Nerve Stimulation (TENS) is a novel pain management device for women suffering from dysmenorrhea

Trial Locations (1)

Unknown

Hadassah, Jerusalem

All Listed Sponsors

lead

iPulse Medical Ltd. (Livia)

INDUSTRY

NCT03064945 - The Effectiveness and Safety of LIVIA® Transcutaneous Electrical Nerve Stimulation (TENS) in Women Suffering From Primary Dysmenorrhea. | Biotech Hunter | Biotech Hunter